The objectives of the Pilot Projects are two-fold. This proposal brings together a group of experts that synergize to provide the best possible program on the topic of Systems Analysis of Vaccine Responses in Healthy and Hyporesponsive Humans. Given the breadth of the topic, we should expect to identify gaps in the repertoire of collective expertise. The first objective of these Pilot Projects will be to fill any knowledge gaps that are identified and expand the discoveries made in the program. The second objective will be to develop areas of research that can expand to independently funded projects in the future. The five years of the program could permit us to support several Pilot Projects. These projects will be financed for up to two years. It is proposed that each Pilot Project will be overseen/chaperoned from inception to completion by two of the program's investigators. The proposed Pilot Projects are: Pilot Project 1: DNA Template Recycling for Deep Sequencing and Identification of Immunoglobulin VDJ gene Usage in Response to Influenza Vaccine (Co-PIs: Nader Pourmand, David Haussler, and Martha Zuniga;University of California Santa Cruz) Pilot Project 2: Deep Sequence Analysis of B-Cell Responses to Vaccines in SLE Patients with High IFN alpha and Low IFN alpha Signatures and in JDM Patients (Co-PIs: Martha Zuniga, David Haussler, and Nader Pourmand;University of California Santa Cruz) Pilot Project 3: To Investigate the Effect of IL-12/IL-23 Blockade on Response to Vaccination in Patients with Chronic Plaque Psoriasis (PI: Alan Menter;Texas Dermatology Associates, PA &Baylor Institute for Immunology Research)

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI089987-04
Application #
8501332
Study Section
Special Emphasis Panel (ZAI1-QV-I)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$8,315
Indirect Cost
$1,837
Name
Baylor Research Institute
Department
Type
DUNS #
145745022
City
Dallas
State
TX
Country
United States
Zip Code
75204
Cepika, Alma-Martina; Banchereau, Romain; Segura, Elodie et al. (2017) A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis. J Exp Med 214:3449-3466
Athale, Shruti; Banchereau, Romain; Thompson-Snipes, LuAnn et al. (2017) Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets. Sci Transl Med 9:
Schotsaert, Michael; García-Sastre, Adolfo (2017) Inactivated influenza virus vaccines: the future of TIV and QIV. Curr Opin Virol 23:102-106
Silvin, Aymeric; Yu, Chun I; Lahaye, Xavier et al. (2017) Constitutive resistance to viral infection in human CD141+ dendritic cells. Sci Immunol 2:
Sandoval, Carmen; Barrera, Aldo; Ferrés, Marcela et al. (2016) Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic. PLoS One 11:e0147271
Heinonen, Santtu; Jartti, Tuomas; Garcia, Carla et al. (2016) Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis. Am J Respir Crit Care Med 193:772-82
Blohmke, Christoph J; Darton, Thomas C; Jones, Claire et al. (2016) Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever. J Exp Med 213:1061-77
Schmitt, Nathalie; Liu, Yang; Bentebibel, Salah-Eddine et al. (2016) Molecular Mechanisms Regulating T Helper 1 versus T Follicular Helper Cell Differentiation in Humans. Cell Rep 16:1082-1095
Bentebibel, Salah-Eddine; Khurana, Surender; Schmitt, Nathalie et al. (2016) ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination. Sci Rep 6:26494
Suarez, Nicolas M; Bunsow, Eleonora; Falsey, Ann R et al. (2015) Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults. J Infect Dis 212:213-22

Showing the most recent 10 out of 57 publications